{"id":"https://openalex.org/W2409415403","doi":null,"title":"Treatment-resistant schizophrenia: challenges and implications for clinical practice.","display_name":"Treatment-resistant schizophrenia: challenges and implications for clinical practice.","publication_year":2015,"publication_date":"2015-09-01","ids":{"openalex":"https://openalex.org/W2409415403","mag":"2409415403","pmid":"https://pubmed.ncbi.nlm.nih.gov/26400145"},"language":"en","primary_location":{"id":"pmid:26400145","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26400145","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatria Danubina","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hrcak.srce.hr/162492","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081886491","display_name":"Marina \u0160agud","orcid":"https://orcid.org/0000-0001-9620-2181","observed_orcids":["https://orcid.org/0000-0001-9620-2181"]},"institutions":[{"id":"https://openalex.org/I138937732","display_name":"University Hospital Centre Zagreb","ror":"https://ror.org/00r9vb833","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I138937732"]}],"countries":["HR"],"is_corresponding":true,"raw_author_name":"Marina \u0160agud","raw_affiliation_strings":["University Hospital Centre Zagreb, Department of Psychiatry, Ki\u0161pati\u0107eva 12, 10 000 Zagreb, Croatia, MarinaSagud@mail.com","University Hospital Centre Zagreb, Department of Psychiatry, Kispaticeva 12, 10 000 Zagreb, Croatia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Centre Zagreb, Department of Psychiatry, Ki\u0161pati\u0107eva 12, 10 000 Zagreb, Croatia, MarinaSagud@mail.com","institution_ids":["https://openalex.org/I138937732"]},{"raw_affiliation_string":"University Hospital Centre Zagreb, Department of Psychiatry, Kispaticeva 12, 10 000 Zagreb, Croatia","institution_ids":["https://openalex.org/I138937732"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5081886491"],"corresponding_institution_ids":["https://openalex.org/I138937732"],"apc_list":null,"apc_paid":null,"fwci":1.3542,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.7998994,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"27","issue":"3","first_page":"319","last_page":"26"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/treatment-resistant-schizophrenia","display_name":"treatment-resistant schizophrenia","score":1.0},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.949999988079071},{"id":"https://openalex.org/keywords/electroconvulsive-therapy","display_name":"electroconvulsive therapy","score":0.9240000247955322},{"id":"https://openalex.org/keywords/antipsychotic-non-adherence","display_name":"antipsychotic non-adherence","score":0.9169999957084656},{"id":"https://openalex.org/keywords/dopaminergic-system","display_name":"dopaminergic system","score":0.7559999823570251},{"id":"https://openalex.org/keywords/glutamatergic-system","display_name":"glutamatergic system","score":0.9660000205039978},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.8149999976158142},{"id":"https://openalex.org/keywords/neurodegeneration","display_name":"neurodegeneration","score":0.8679999709129333},{"id":"https://openalex.org/keywords/clozapine-resistance","display_name":"clozapine resistance","score":0.7289999723434448},{"id":"https://openalex.org/keywords/augmentation-strategies","display_name":"augmentation strategies","score":0.7009999752044678},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9629999995231628},{"id":"https://openalex.org/keywords/hormone-therapy","display_name":"hormone therapy","score":0.7689999938011169}],"concepts":[{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.8729026317596436},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7465648651123047},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5650936365127563},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.4823274314403534},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.47467517852783203},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4173338711261749},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.3669009506702423},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.35654205083847046},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20132866501808167}],"mesh":[{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:26400145","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26400145","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatria Danubina","raw_type":"Journal Article"},{"id":"pmh:oai:hrcak.srce.hr:162492","doi":null,"is_oa":true,"landing_page_url":"http://hrcak.srce.hr/162492","pdf_url":null,"source":{"id":"https://openalex.org/S4306400071","display_name":"University of Zagreb University Computing Centre (SRCE)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I181343428","host_organization_name":"University of Zagreb","host_organization_lineage":["https://openalex.org/I181343428"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Psychiatria Danubina","raw_type":"info:eu-repo/semantics/conferenceObject"},{"id":"mag:2409415403","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26400145","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:hrcak.srce.hr:162492","doi":null,"is_oa":true,"landing_page_url":"http://hrcak.srce.hr/162492","pdf_url":null,"source":{"id":"https://openalex.org/S4306400071","display_name":"University of Zagreb University Computing Centre (SRCE)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I181343428","host_organization_name":"University of Zagreb","host_organization_lineage":["https://openalex.org/I181343428"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Psychiatria Danubina","raw_type":"info:eu-repo/semantics/conferenceObject"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W1675579112","https://openalex.org/W1967050451","https://openalex.org/W1967358927","https://openalex.org/W1970135881","https://openalex.org/W1975122441","https://openalex.org/W1989106741","https://openalex.org/W1993866915","https://openalex.org/W2005575607","https://openalex.org/W2008349757","https://openalex.org/W2011726550","https://openalex.org/W2022320465","https://openalex.org/W2030324175","https://openalex.org/W2036480935","https://openalex.org/W2037820216","https://openalex.org/W2040533287","https://openalex.org/W2047547804","https://openalex.org/W2081633015","https://openalex.org/W2082332151","https://openalex.org/W2083767722","https://openalex.org/W2084250773","https://openalex.org/W2085360366","https://openalex.org/W2086982565","https://openalex.org/W2090110166","https://openalex.org/W2092820864","https://openalex.org/W2096987707","https://openalex.org/W2100382251","https://openalex.org/W2101644005","https://openalex.org/W2106675797","https://openalex.org/W2121119246","https://openalex.org/W2125320544","https://openalex.org/W2129662856","https://openalex.org/W2138231636","https://openalex.org/W2138567287","https://openalex.org/W2154296992","https://openalex.org/W2161503386","https://openalex.org/W2469242524","https://openalex.org/W3115493962","https://openalex.org/W4415404273"],"related_works":["https://openalex.org/W7172007973","https://openalex.org/W7171951357","https://openalex.org/W2889058327","https://openalex.org/W6902210058","https://openalex.org/W7211993809","https://openalex.org/W4414181472","https://openalex.org/W1998347564","https://openalex.org/W2009097496","https://openalex.org/W2171233216","https://openalex.org/W2964622385"],"abstract_inverted_index":{"Despite":[0],"pharmacological":[1],"advances":[2],"in":[3,50,69,76,83],"the":[4,118],"treatment":[5,64],"of":[6,10,18,26,29,78,89,122],"schizophrenia,":[7],"significant":[8],"number":[9],"patients":[11,90],"continue":[12],"to":[13,23,97],"be":[14,21,43],"treatment-resistant.":[15],"Poor":[16],"control":[17],"symptoms":[19],"could":[20],"related":[22],"low":[24],"concentration":[25],"antipsychotics":[27],"because":[28],"non-adherence":[30],"or":[31,95],"pharmacokinetic":[32],"issues.":[33],"However,":[34,85],"there":[35,124],"is":[36,60,74,115,125],"growing":[37],"evidence":[38,114],"that":[39],"\"true\"":[40],"treatment-resistance":[41],"might":[42],"associated":[44],"with":[45,91],"biological":[46],"changes,":[47],"i.e.":[48],"alterations":[49],"dopaminergic":[51],"and":[52,57,99,106,120,144],"glutaminergic":[53],"systems,":[54],"genetics,":[55],"neurodegeneration":[56],"neuroinflamation.":[58],"Clozapine":[59],"recommended":[61],"as":[62,137],"first-line":[63],"for":[65,129],"treatment-resistant":[66],"schizophrenia":[67],"(TRS)":[68],"all":[70],"guidelines.":[71],"Clozapine-ECT":[72],"combination":[73,105],"effective":[75],"majority":[77],"those":[79],"patients,":[80],"at":[81],"least":[82],"short-term.":[84],"more":[86,100],"than":[87],"half":[88],"TRS":[92],"have":[93],"resistance":[94],"intolerance":[96],"clozapine,":[98],"interventions":[101],"are":[102,147],"needed.":[103],"Different":[104],"augmentation":[107],"strategies":[108,133],"may":[109],"offer":[110],"some":[111],"advantage,":[112],"but":[113],"limited.":[116],"Given":[117],"severity":[119],"complexity":[121],"TRS,":[123],"an":[126],"urgent":[127],"need":[128],"better":[130],"treatment.":[131],"Treatment":[132],"beyond":[134],"dopamine,":[135],"such":[136],"glutamate-modelling":[138],"agents,":[139],"nonsteroidal":[140],"anti-inflammatory":[141],"drugs":[142],"(NSAIDs)":[143],"hormonal":[145],"treatment,":[146],"under":[148],"investigation.":[149]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}